Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-29 Sale | 2024-03-01 5:49 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 8,661 | $1.58 | $13,684 | 706,932 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 6:02 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 10,744 | $1.52 | $16,331 | 715,593 (Direct) | View |
| 2023-05-25 Sale | 2023-05-25 9:01 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 95,478 | $1.2229 | $116,760 | 774,037 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 20,412 | $0.8775 | $17,912 | 269,515 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:06 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 10,090 | $0.8132 | $8,205 | 289,927 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:11 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 21,533 | $2.1659 | $46,637 | 497,017 (Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:33 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 1,211 | $3.4 | $4,117 | 265,550 (Direct) | View |
| 2021-03-01 Sale | 2021-03-02 4:08 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 14,547 | $3.3961 | $49,403 | 365,113 (Direct) | View |
| 2020-02-28 Sale | 2020-03-02 7:29 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 6,972 | $8.7 | $60,656 | 324,960 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-02-02 4:11 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 373,300 | $0 | 950,337 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 9:01 pm | N/A 2032-05-12 | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 200,000 | $0 | 774,037 (Direct) | View |
| 2023-05-12 Option Award | 2023-05-16 4:09 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 200,000 | $0 | 469,515 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:11 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 250,000 | $0 | 497,017 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:17 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 11,648 | $0 | 266,761 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:08 pm | N/A 2031-02-26 | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 172,000 | $0 | 365,113 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-02 7:29 pm | N/A 2030-02-28 | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 185,000 | $0 | 324,960 (Direct) | View |